Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01463280 · ClinicalTrials.gov registry record · Phase 1
Effect of Tumescent Lidocaine on Platelet Function
A Phase 1 study, sponsored by Klein, Jeffrey A., M.D..
- Completed
- Registry status
- Phase 1
- Development phase
- 129
- Enrollment target
NCT01463280: Completed Phase 1 study, sponsored by Klein, Jeffrey A., M.D..
NCT01463280 is a Phase 1 study that has completed, run by Klein, Jeffrey A., M.D.. The registered enrollment target is 129 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (115% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01463280, a Phase 1 study, has completed, sponsored by Klein, Jeffrey A., M.D..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 129 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of lidocaine, delivered into subcutaneous tissue for tumescent local anesthesia, on platelet activation following the tumescent liposuction.
Primary Outcome
The purpose of the present research project is to study how platelet function after surgical trauma (liposuction) is affected by tumescent lidocaine. We hypothesize that lidocaine, delivered in the form of tumescent local anesthesia, inhibits surgical trauma-induced platelet activation as measured by the in-vivo Klein Bleeding Area test (www.onlinePFT).
Interventions
- DRUG tumescent lidocaine infiltration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-12 |
| Phase | Phase 1 |
What the finished NCT01463280 record still lists
NCT01463280 is an interventional study that assigns participants to a tested intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (115% higher).
The record links to 0 conditions, and to 1 intervention - of which tumescent lidocaine infiltration is the first listed.
NCT01463280 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01463280 about?
NCT01463280 is a clinical study titled "Effect of Tumescent Lidocaine on Platelet Function". The purpose of this study is to evaluate the effect of lidocaine, delivered into subcutaneous tissue for tumescent local anesthesia, on platelet activation following the tumescent liposuction.
What is the current status of trial NCT01463280?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 129 participants. The study started on 2011-01. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01463280?
The interventions under investigation include: tumescent lidocaine infiltration (DRUG).
Who is sponsoring clinical trial NCT01463280?
This trial is sponsored by Klein, Jeffrey A., M.D., which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01463280's enrollment target sits among peer trials
129 451st of 2000 higher than 1,549 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03619850 · 129 participants · Phase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- NCT05704361 · 129 participants · Phase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
- NCT05919849 · 129 participants · Phase 1
Supporting Parents in Affirming Their Children's Experiences of Stigma
- NCT06313749 · 129 participants · NA
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia